Clinical Trial Update: Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion and posted results of a Phase 1/2 trial evaluating pembrolizumab in combination with gemcitabine chemotherapy in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• Gemzar (gemcitabine)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-02-13